| 32.99 Data as of May 24 |  -0.33 / -0.99%Today’s Change | 20.04 Today|||52-Week Range 37.40 | +37.63% Year-to-Date |
| Why The Medicines Company May Be About to Take Off May 16 / MotleyFool.com | Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog May 15 / Zacks.com |
| Previous close | 33.32 |
| Today’s open | 33.04 |
| Day’s range | 32.51 - 33.35 |
| Volume | 756,270 |
| Average volume (3 months) | 876,916 |
| Market cap | $1.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -60.43% |
| Earnings growth (this year) | +5.15% |
| Earnings growth (next 5 years) | +31.50% |
| Revenue growth (last year) | +15.24% |
| P/E ratio | 55.9 |
| Price/Sales | 2.30 |
| Price/Book | 3.04 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARNAArena Pharmaceutical... | +0.24 | +2.99% |
| MNKDMannkind Corp | -0.30 | -4.38% |
| VPHMViroPharma Inc | +0.60 | +2.27% |
| QCORQuestcor Pharmaceuti... | -0.43 | -1.22% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.32 |
| Annual revenue (last year) | $558.6M |
| Annual profit (last year) | $51.3M |
| Net profit margin | 9.18% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Clive A. Meanwell, MD, PhD |
President, CFO, Treasurer & Director Glenn P. Sblendorio, MBA |
Corporate headquarters Parsippany, New Jersey |
.
